DK1560594T3 - Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi - Google Patents

Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi

Info

Publication number
DK1560594T3
DK1560594T3 DK03751693.7T DK03751693T DK1560594T3 DK 1560594 T3 DK1560594 T3 DK 1560594T3 DK 03751693 T DK03751693 T DK 03751693T DK 1560594 T3 DK1560594 T3 DK 1560594T3
Authority
DK
Denmark
Prior art keywords
immunization
equi
human mammals
subsp
mammals against
Prior art date
Application number
DK03751693.7T
Other languages
English (en)
Inventor
Bengt Guss
Jan-Ingmar Flock
Karin Jacobsson
Kenneth Janzon
Lars Frykberg
Margareta Flock
Rune Bergman
Original Assignee
Bengt Guss
Jan-Ingmar Flock
Karin Jacobsson
Kenneth Janzon
Lars Frykberg
Margareta Flock
Rune Bergman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Guss, Jan-Ingmar Flock, Karin Jacobsson, Kenneth Janzon, Lars Frykberg, Margareta Flock, Rune Bergman filed Critical Bengt Guss
Application granted granted Critical
Publication of DK1560594T3 publication Critical patent/DK1560594T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK03751693.7T 2002-10-11 2003-10-10 Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi DK1560594T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41766002P 2002-10-11 2002-10-11
PCT/SE2003/001587 WO2004032957A1 (en) 2002-10-11 2003-10-10 Immunization of non-human mammals against streptococcus equi

Publications (1)

Publication Number Publication Date
DK1560594T3 true DK1560594T3 (da) 2010-10-04

Family

ID=32094057

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03751693.7T DK1560594T3 (da) 2002-10-11 2003-10-10 Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi

Country Status (9)

Country Link
US (1) US8404245B2 (da)
EP (1) EP1560594B1 (da)
AT (1) ATE471156T1 (da)
AU (1) AU2003269765B2 (da)
CA (1) CA2501621C (da)
DE (1) DE60333027D1 (da)
DK (1) DK1560594T3 (da)
NZ (1) NZ539255A (da)
WO (1) WO2004032957A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
WO2007115059A2 (en) 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
US20110020403A1 (en) * 2007-12-13 2011-01-27 Bengt Guss immunizing composition
WO2011059385A1 (en) * 2009-11-13 2011-05-19 Bengt Guss Immunizing composition for reducing streptococcal infections
WO2011149419A1 (en) 2010-05-26 2011-12-01 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
CN103958542A (zh) * 2011-09-23 2014-07-30 抗菌技术,生物技术研究与发展股份有限公司 经修饰的白蛋白结合结构域及其用于改善药代动力学的用途
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
CN120173928B (zh) * 2025-05-22 2025-09-19 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种前噬菌体裂解酶及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES76925B2 (en) 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein

Also Published As

Publication number Publication date
NZ539255A (en) 2007-12-21
EP1560594B1 (en) 2010-06-16
US8404245B2 (en) 2013-03-26
ATE471156T1 (de) 2010-07-15
HK1085646A1 (en) 2006-09-01
AU2003269765A1 (en) 2004-05-04
AU2003269765B2 (en) 2009-08-06
WO2004032957A1 (en) 2004-04-22
US20060140980A1 (en) 2006-06-29
EP1560594A1 (en) 2005-08-10
CA2501621A1 (en) 2004-04-22
DE60333027D1 (de) 2010-07-29
CA2501621C (en) 2012-01-24

Similar Documents

Publication Publication Date Title
ATE513560T1 (de) Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird
DE60044570D1 (de) Verbindungen mit immunologischem Adjuvanseffekt
CY1117957T1 (el) Συμπληρωμενο omv εμβολιο εναντι μηνιγγιοκοκκου
WO2005037190A3 (en) Multiplex vaccines
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
NO975620D0 (no) Immunologiske kombinasjonssammensetninger og fremgangsmåter
ATE501726T1 (de) Zusammensetzung mit immunogenen mikroteilchen
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
DE60235155D1 (de) Monoklonale antikörper gegen molekulare mimetika von meningokokken-b-epitopen
DK1560594T3 (da) Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi
WO2003070282A3 (en) Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
YU24004A (sh) Interleukin-12 kao adjuvant veterinarske vakcine
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
ATE392216T1 (de) Mycobakterieller impfstoff
WO2005028618A3 (en) Immunogenic compositions for streptococcus agalactiae
ATE364395T1 (de) Konjugat-impfstoffe zur vorbeugung der zahnkaries
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
DK0757556T3 (da) Borrelia Burgdorferi-bakterin
WO2003075845A3 (en) Immunogenicity of glucan binding protein
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
WO2007062832A3 (en) Vaccines containing non-live antigenic vectors
EA200400897A1 (ru) Иммуногенные композиции из вариабельных пептидных эпитопов и способ их получения
ATE375170T1 (de) Adjuvanskombinationen zur immunisierung und vakzine
DK1442124T3 (da) Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden